Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Vincent van Almsick"'
Autor:
Annika Sobkowiak, Natalie Scherff, Franziska Schuler, Stefan Bletz, Alexander Mellmann, Vera Schwierzeck, Vincent van Almsick
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 14 (2024)
IntroductionThe emergence of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae is an urgent and alarming One Health problem. This study aimed to investigate duplications of plasmid-encoded ESBL genes and their impact on antimicrobial
Externí odkaz:
https://doaj.org/article/edd2e9cf3ace44a5a28e59c97ba1c126
Autor:
Bernhard Ohnewein, Zornitsa Shomanova, Vera Paar, Albert Topf, Peter Jirak, Lukas Fiedler, Christina Granitz, Vincent Van Almsick, Dilvin Semo, Naufal Zagidullin, Anna-Maria Dieplinger, Juergen Sindermann, Holger Reinecke, Uta C. Hoppe, Rudin Pistulli, Lukas J. Motloch
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 9, p 3083 (2023)
(1) Background: Heart failure with reduced ejection fraction (HFrEF) remains a major health burden. Angiotensin-Receptor-Neprilysin-Inhibitors (ARNIs) are an established HFrEF therapy which increases natriuretic peptide levels by inhibiting neprilysi
Externí odkaz:
https://doaj.org/article/eef304b624da441782d11491e2b915d3
Autor:
Peter Jirak, Vincent van Almsick, Dimitrios Dimitroulis, Moritz Mirna, Clemens Seelmaier, Zornitsa Shomanova, Bernhard Wernly, Dilvin Semo, Daniel Dankl, Magdalena Mahringer, Michael Lichtenauer, Uta C. Hoppe, Holger Reinecke, Rudin Pistulli, Robert Larbig, Lukas J. Motloch
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundSevere COVID-19 pneumonia requiring intensive care treatment remains a clinical challenge to date. Dexamethasone was reported as a promising treatment option, leading to a reduction of mortality rates in severe COVID-19 disease. However, th
Externí odkaz:
https://doaj.org/article/7d2ac64ad9db47f9af6610e76906f0c2
Autor:
Peter Jirak, Moritz Mirna, Vincent Van Almsick, Zornitsa Shomanova, Magdalena Mahringer, Michael Lichtenauer, Kristen Kopp, Albert Topf, Franz Sieg, Johannes Kraus, Sarah X. Gharibeh, Uta C. Hoppe, Lukas Fiedler, Robert Larbig, Rudin Pistulli, Lukas J. Motloch, Anna-Maria Dieplinger
Publikováno v:
Journal of Personalized Medicine, Vol 12, Iss 5, p 849 (2022)
Background: Gender-specific differences in the outcome of COVID-19 patients requiring intensive care treatment have been reported. However, a potential association with ICU therapy remains elusive. Methods: A total of 224 consecutive patients (63 wom
Externí odkaz:
https://doaj.org/article/c51a2d40025f461c8ebdea963bbc05f2
Publikováno v:
Microorganisms, Vol 10, Iss 3, p 491 (2022)
Plasmid transfer is one important mechanism how antimicrobial resistance can spread between different species, contributing to the rise of multidrug resistant bacteria (MDRB) worldwide. Here were present whole genome sequencing (WGS) data of two MDRB
Externí odkaz:
https://doaj.org/article/f7d9a81f09e84b17a05a2695cb3e21e7
Autor:
Peter Jirak, Vincent van Almsick, Dimitrios Dimitroulis, Moritz Mirna, Clemens Seelmaier, Zornitsa Shomanova, Bernhard Wernly, Dilvin Semo, Daniel Dankl, Magdalena Mahringer, Michael Lichtenauer, Uta C. Hoppe, Holger Reinecke, Rudin Pistulli, Robert Larbig, Lukas J. Motloch
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundSevere COVID-19 pneumonia requiring intensive care treatment remains a clinical challenge to date. Dexamethasone was reported as a promising treatment option, leading to a reduction of mortality rates in severe COVID-19 disease. However, th
Publikováno v:
Journal of microbiological methods. 147
Accurate detection of carbapenem-resistant Enterobacteriaceae (CRE) and carbapenemase-producing carbapenem-resistant Acinetobacter spp . (CP-CRA) constitutes a major challenge in laboratory diagnostics. We developed a bioluminescence-based carbapenem